18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities-Reference-Cited by-同舟云学术

18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities

Published:2019-12-06 Issue:1 Volume:48 Page:9-16
ISSN:0091-4916
Container-title:Journal of Nuclear Medicine Technology
language:en
Short-container-title:J. Nucl. Med. Technol.

Author:

Ahuja Kriti,Sotoudeh Houman,Galgano Samuel J.,Singh Ramandeep,Gupta Nishant,Gaddamanugu Siddhartha,Choudhary Gagandeep

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiological and Ultrasound Technology

Reference64 articles.

1. Molecular Imaging in Oncology:18F-Sodium Fluoride PET Imaging of Osseous Metastatic Disease

2. 18-fluoride labeled sodium fluoride positron emission tomography with computer tomography: the impact of pretreatment staging in intermediate- and high-risk prostate cancer;Harley;Prostate Int.,2018

3. Skeletal metastases and benign mimics on NaF PET/CT: a pictorial review;Panagiotidis;AJR.,2018

4. Performance of 18F-Fluoride PET or PET/CT for the Detection of Bone Metastases

5. A meta-analysis of 18F-Fluoride positron emission tomography for assessment of metastatic bone tumor

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging of pain using positron emission tomography;iRADIOLOGY;2024-05-18

2. SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases;Seminars in Nuclear Medicine;2024-05

3. Update on Pediatric Nuclear Medicine in Acute Care;Seminars in Nuclear Medicine;2023-11

4. The influence of cation-exchange cartridge on quality of [18F]NaF radiopharmaceutical;Macedonian Pharmaceutical Bulletin;2023-09

5. Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors;ESMO Open;2023-08